HomeAI · summaries
Storia in 3 fonti
Merck scraps £1bn expansion in the UK over lack of state investment
The firm, known as MSD in Europe, said there has been a lack of investment in life sciences.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
telegraph.co.uk
US drugmaker scraps plans for £1bn UK research centre
Merck criticises ‘successive UK governments’ as it cancels King’s Cross development
- ·
bbc.com
Merck scraps £1bn expansion in the UK over lack of state investment
The firm, known as MSD in Europe, said there has been a lack of investment in life sciences.
- ·
independent.co.uk
Pharma giant ditches £1bn London research hub and says UK ‘not competitive’
Merck, known as MSD in Europe, criticised the UK’s business environment despite the government saying it has become ‘the most attractive place to invest in the world’
- ·
AstraZeneca pauses £200m Cambridge investment
Its decision comes as the industry says there is a lack of government investment and as the US pressures firms to invest there.